{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T15:27:34Z","timestamp":1648567654042},"reference-count":14,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.clinthera.2009.11.006","type":"journal-article","created":{"date-parts":[[2010,1,26]],"date-time":"2010-01-26T09:59:17Z","timestamp":1264499957000},"page":"2559-2564","source":"Crossref","is-referenced-by-count":1,"title":["Management of refractory essential thrombocythemia with anagrelide in a patient undergoing hemodialysis"],"prefix":"10.1016","volume":"31","author":[{"given":"Maria do Carmo Filomena","family":"Mesquita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eug\u00e9nie Bakoto","family":"Sol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Malarme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Noubouossie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Claire","family":"Demulder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2009.11.006_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1750-1172-2-3","article-title":"Essential thrombocythemia","volume":"2","author":"Bri\u00e8re","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clinthera.2009.11.006_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa043800","article-title":"Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia","volume":"353","author":"Harrison","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2009.11.006_bib3","series-title":"Agrylin (anagrelide hydrochloride) capsules","year":"2004"},{"key":"10.1016\/j.clinthera.2009.11.006_bib4","series-title":"Agrylin (anagrelide hydrochloride) capsules","year":"2007"},{"key":"10.1016\/j.clinthera.2009.11.006_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00003495-200666010-00006","article-title":"Anagrelide: A review of its use in the management of essential thrombocythaemia","volume":"66","author":"Wagstaff","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2009.11.006_bib8","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMra035363","article-title":"Thrombocytosis","volume":"350","author":"Schafer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2009.11.006_bib9","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (IARC WHO Classification of Tumours)","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.clinthera.2009.11.006_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00277-008-0531-7","article-title":"Long term management of thrombocytosis in essential thrombocythaemia","volume":"88","author":"Birgeg\u00e5rd","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clinthera.2009.11.006_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000111776","article-title":"Effect of anagrelide on platelet coagulant function in patients with essential thrombocythemia","volume":"118","author":"Cacciola","year":"2007","journal-title":"Acta Haematol"},{"issue":"Suppl 5","key":"10.1016\/j.clinthera.2009.11.006_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/ndt\/17.suppl_5.32","article-title":"Anaemia, rHuEPO resistance, and cardiovascular disease in end-stage renal failure; links to inflammation and oxidative stress","volume":"17","author":"Stenvinkel","year":"2002","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2009.11.006_bib13","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1093\/ndt\/gfh1032","article-title":"Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure","volume":"19","author":"Locatelli","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2009.11.006_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2257.2004.00637.x","article-title":"Anagrelide treatment in 52 patients with chronic myeloproliferative diseases","volume":"26","author":"Penninga","year":"2004","journal-title":"Clin Lab Haematol"},{"key":"10.1016\/j.clinthera.2009.11.006_bib15","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1600-0609.1998.tb01040.x","article-title":"Plasma erythropoietin by high-detectibility immunoradiometric assay in untreated and treated patients with polycythaemia vera and essential thrombocythaemia","volume":"60","author":"Carneskog","year":"1998","journal-title":"EurJ Haematol"},{"key":"10.1016\/j.clinthera.2009.11.006_bib16","first-page":"520","article-title":"Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders","volume":"89","author":"Birgeg\u00e5rd","year":"2004","journal-title":"Haematologica"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809003968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291809003968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T19:51:27Z","timestamp":1544730687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291809003968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":14,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0149291809003968"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2009.11.006","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}